Company Research Report: Multiply Labs, Inc.

Company Overview

• Name: Multiply Labs, Inc.

• Mission of the Company: Multiply Labs believes in a world where every patient has access to next-generation, precision medicines. Their robotic technology is considered the gold standard for manufacturing life-saving products.

• Founded By: The company was founded by Fred Parietti, Ph.D., and Alice Melocchi.

• Key People:

• Fred Parietti, Ph.D. - Co-Founder & CEO

• Jeff Curhan - VP of Robotics

• Alice Melocchi - Co-Founder & CSO

• Sonali Tanor - COO

• Advisors include Mike Doherty, Joe Betts-LaCroix, Bo Zhou, MSc, PhD, Thomas Gaziano, MD, MSc, Vincent Chan, Scott Dylla, PhD, Throop Wilder, Carlos Parra, Leandro Agro, and Jonathan Esensten.

• Headquarters:

• 1040 Mariposa Street, San Francisco, CA 94107

• Number of Employees: No information is available.

• Revenue: No information is available.

• What the Company is Known For: Multiply Labs is known for their robotic systems that manufacture precision medicines for patients, specifically focusing on gene-modified cell therapies and automated capsule production.

Products

• Robotic Systems for Cell Therapy Manufacturing:

• Description: These systems are designed to manufacture gene-modified cell therapies on an industrial scale.

• Key Features:

• Compatible with market-leading GMP instruments.

• Modular and flexible design allows for customized configurations.

• High throughput with multiple modules operating in parallel.

• Digital Process Control: Digital QC:

• Description: An automation software that records every aspect of the drug manufacturing process.

• Key Features:

• Works on-premises and in the cloud.

• CFR Part 11 compliant.

• Automated data collection with 100% traceability.

• Enables a shift from traditional (post-process) to advanced (in-process) quality control.

• Robotic Systems for Capsule Manufacturing:

• Description: Systems to manufacture any type of capsular products for precision medicine at an industrial scale.

• Key Features:

• Can produce multiple precision drug products in parallel.

• Operated entirely by robotic systems with digital quality control.

Recent Developments

• Recent Collaborations:

• Stanford GMP Facility: Collaboration to deploy robotic systems at the Laboratory for Cell and Gene Medicine.

• GenScript: Partnership to automate the cell isolation and enrichment phase of cell therapy manufacturing.

• Wilson Wolf Manufacturing, LLC: Teamed up to automate G-Rex® bioreactors.

• New Partnerships:

• WuXi STA: Partnership and successful deployment of a robotic manufacturing system for personalized drugs.

• Product Developments:

• Digital QC continuously advancing with new features allowing enhanced process data measurement and logging.

• Introduction of a patented multi-compartment capsule filling technology capable of holding different formulations in up to four compartments.

• Consortium Involvement:

• Multiple notable partnerships with Cytiva, Thermo Fisher, and Charles River Laboratories to advance cell therapy manufacturing.

In summary, Multiply Labs, Inc. has made significant contributions to the life sciences industry by developing robotic systems for cell therapy and capsule manufacturing. Their emphasis on digital automation and quality control positions them uniquely in the market to deliver next-gen, precision medicine manufacturing solutions at scale.